Determinants of environmental quality in India: evidence using the bootstrapped ARDL model with structural breaks.

This current study examines the impact of renewable energy consumption, agriculture, and globalization on carbon emissions in India over the period from 1980 to 2018. For long-run estimates, we apply Gregory-Hansen's co-integration test, bootstrap ARDL approaches, fully modified ordinary least squares, and dynamic OLS. The empirical results of long-run estimates indicate that a 1% increase in renewable energy consumption, agriculture, and economic globalization will increase carbon emissions by 0.764%, 1.675%, and 0.517%, respectively. Moreover, this study confirms the detrimental effect of these variables on carbon dioxide emissions. Economic globalization coefficients indicate that the scale effect is valid in India. The 2002 economic crisis slowed down the country's growth rate, which reduced the ecological pollution. Several policy recommendations are derived from the empirical findings.

Carbon dioxide intensity of GDP and environmental degradation in an emerging country.

This paper investigates whether the carbon dioxide (CO2) intensity of GDP matters for environmental degradation in an emerging country, namely, Turkey, over the period of 1990-2018 while controlling economic growth, foreign direct investment, and renewable energy consumption. The present study uses both linear and nonlinear time series estimators, namely, the Gregory and Hansen cointegration test, bounds test, nonlinear autoregressive distributed lag (NARDL) model, fully modified ordinary least squares (FMOLS), dynamic ordinary least squares (DOLS), and canonical cointegrating regressions (CCR), to encapsulate the possible effect of CO2 intensity of GDP, economic growth, foreign direct investment, and renewable energy consumption on environmental degradation in Turkey. The empirical finding of the present study reveals that the CO2 intensity of GDP is an important factor to determine environmental degradation in Turkey and the declining CO2 intensity of GDP reduces environmental degradation. Moreover, economic growth is the primary environmental sustainability factor in Turkey. The result is vital for policymaking and can perhaps be applied to take decisive policy actions to mitigate environmental issues.

The asymmetric effect of renewable energy and trade on consumption-based CO2 emissions: The case of Italy.

Although numerous studies in the literature have been conducted to model CO2 emissions, there is a lack of empirical knowledge of consumption-based CO2 emissions, which are adjusted for international trade, specifically. Therefore, the present study aims to close this gap in the literature in the case of Italy, while capturing the asymmetric effect of trade, renewable energy, and economic growth on consumption-based CO2 emissions. The present study uses the Gregory-Hansen test for cointegration with regime shifts, Markov switching regression, nonlinear autoregressive distributed lag (NARDL), and frequency domain causality test. The study's outcomes reveal that (1) the asymmetric effect of import on consumption-based CO2 emissions is positive, implying that rising import is associated with declining consumption-based environmental quality; (2) export, renewable consumption, and economic growth reduce consumption-based CO2 emissions in Italy. Moreover, these outcomes are supported by the outcomes of the frequency domain causality test. These innovative insights may prompt policy-makers to implement eco-friendly methods, such as renewable energy distribution and environmental innovation, to achieve a greener future. Integr Environ Assess Manag 2022;18:784-795. © 2021 SETAC.

Why are emerging countries popular for clinical research?

BACKGROUND: The business of clinical research has changed in the past two decades, shifting from industrialised Western countries to so-called emerging markets such as Eastern Europe, Latin America and Africa. An appraisal of the trends could identify associated factors that may have implications for the local populations and their endemic diseases. OBJECTIVES: To identify potential reasons why emerging countries have become attractive places for international sponsors to conduct their clinical trials. METHODS: Using ClinicalTrials.gov, the Pan African Clinical Trials Registry, the National Health Research Database and the Nigeria Clinical Trials Registry, trend data on clinical research development were determined for two emerging African markets, Nigeria and South Africa (SA), from 2010 to 2018. Also, health data on the two countries from the fact sheets of health statistics of the World Health Organization were compared, as well as regulatory and ethical conditions. Available data were analysed using descriptive statistics and trend analysis. RESULTS: The impact of globalisation is evident from the upward trend in clinical trials in SA before 2010, and the clear downward trend thereafter. One reason for this change could be the alignment of SA's regulatory and ethical frameworks with the Western world. In contrast, the upward trend is only just beginning in Nigeria, with the introduction of ethical/regulatory frameworks, and supportive institutions making the business of clinical research more attractive on an international level. Although the number of international and local sponsors increased in Nigeria from 2010 to 2018, only the latter increased in SA, with the former decreasing over the same period. Overall, there is a mismatch between country-specific diseases and the drugs being tested, to the extent that leprosy, which is endemic in Nigeria, and tuberculosis in SA were not in the list of top 10 study areas in either country. CONCLUSIONS: The globalisation trend is evident in the clinical trials business, but cannot be generalised to all emerging countries. Timing and intensity vary from country to country relative to factors that advance the existing profit-orientated business models of the sponsors. Furthermore, various diseases have been localised, which entails a diversely increasing need for research.

Have FDI quantity and quality promoted the low-carbon development of science and technology parks (STPs)? The threshold effect of knowledge accumulation.

In recent times, China has emphasized five major development concepts to promote high-quality development: coordination, green, innovation, openness, and sharing. As a metamorphosis of these ideas, Chinese science and technology parks (STPs) are gathering areas of high-tech industries and represent advanced productive forces. Their greenness, openness, and innovative developments herald the future development trends of China. Based on the data of 52 STPs in China from 2011 to 2018, this study analyzes the impact of foreign direct investment (FDI) quantity and quality on the low-carbon development of the STPs. We use Hansen's nonlinear panel threshold regression model with knowledge accumulation as the threshold variable. The results show the following: First, there are complex nonlinear relationships between FDI quantity, FDI quality, and the low-carbon development of the STPs. Second, FDI quantity has a significant positive impact on the low-carbon development of the STPs only when the level of knowledge accumulation is below a certain threshold. Beyond this threshold the effect is no longer significant. Third, FDI quality has a significant positive impact on the low-carbon development of STPs only when the level of knowledge accumulation is lower than a certain threshold; beyond which, the impact is no longer significant. These results can serve as a reference for China to effectively promote economic low-carbon growth of STPs and achieve green, open, and innovative development.

Patent landscape of neglected tropical diseases: an analysis of worldwide patent families.

BACKGROUND: "Neglected Tropical Diseases" (NTDs) affect millions of people in Africa, Asia and South America. The two primary ways of strategic interventions are "preventive chemotherapy and transmission control" (PCT), and "innovative and intensified disease management" (IDM). In the last 5 years, phenomenal progress has been achieved. However, it is crucial to intensify research effort into NTDs, because of the emerging drug resistance. According to the World Health Organization (WHO), the term NTDs covers 17 diseases, namely buruli ulcer, Chagas disease, dengue, dracunculiasis, echinococcosis, trematodiasis, human African trypanosomiasis, leishmaniasis, leprosy, lymphatic filariasis, onchocerciasis, rabies, schistosomiasis, soil-transmitted helminthes, taeniasis, trachoma, and yaws. The aim of this study is to map out research and development (R&D) landscape through patent analysis of these identified NTDs. To achieve this, analysis and evaluation have been conducted on patenting trends, current legal status of patent families, priority countries by earliest priority years and their assignee types, technological fields of patent families over time, and original and current patent assignees. MAIN BODY: Patent families were extracted from Patseer, an international database of patents from over 100 patent issuing authorities worldwide. Evaluation of the patents was carried out using the combination of different search terms related to each identified NTD. In this paper, a total number of 12,350 patent families were analyzed. The main countries with sources of inventions were identified to be the United States (US) and China. The main technological fields covered by NTDs patent landscape are pharmaceuticals, biotechnology, organic fine chemistry, analysis of biological materials, basic materials chemistry, and medical technology. Governmental institutions and universities are the primary original assignees. Among the NTDs, leishmaniasis, dengue, and rabies received the highest number of patent families, while human African trypanosomiasis (sleeping sickness), taeniasis, and dracunciliasis received the least. The overall trend of patent families shows an increase between 1985 and 2008, and followed by at least 6 years of stagnation. CONCLUSION: The filing pattern of patent families analyzed undoubtedly reveals slow progress on research and development of NTDs. Involving new players, such as non-governmental organizations may help to mitigate and reduce the burden of NTDs.

[Leprosy and human rights: trends in Japan and in the world].

Leprosy, or Hansen's disease, has long been regarded as an incurable and dreadful contagious disease. The patients have been forcefully hospitalized and deprived of many basic human rights. Their family members have often been discriminated against due to stigma associated with this disease. Soon after the Second World War, a specific remedy called "multi-drug therapy" (MDT) was discovered and leprosy became a relatively easily curable disease. Despite this medical development, it took time to change the policy and legislation of forceful hospitalization of leprosy patients. The stigma surrounding leprosy and consequent discrimination have continued. In Japan, it was only in 1996 that the legislation requiring forceful hospitalization of leprosy patients was repealed. The Government decided to provide remedies to the former patients who had suffered from this policy. At the United Nations, the General Assembly adopted a resolution to eradicate discrimination against persons affected by leprosy and their family members. It is hoped that discrimination associated with Hansen's disease will soon be overcome by the efforts of all concerned, particularly doctors and nurses who are specialists of this disease.

Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century.

The Titanic has become a metaphor for the disastrous consequences of an unqualified belief in the safety and invincibility of new technology. Similarly, the thalidomide tragedy stands for all of the "monsters" that can be inadvertently or negligently created by modern medicine. Thalidomide, once banned, has returned to the center of controversy with the Food and Drug Administration's (FDA's) announcement that thalidomide will be placed on the market for the treatment of erythema nodosum leprosum, a severe dermatological complication of Hansen's disease. Although this indication is very restricted, thalidomide will be available for off-label uses once it is on the market. New laws regarding abortion and a new technology, ultrasound, make reasonable the approval of thalidomide for patients who suffer from serious conditions it can alleviate. In addition, the FDA and the manufacturer have proposed the most stringent postmarketing monitoring ever used for a prescription drug, including counseling, contraception, and ultrasonography in the event of pregnancy. The Titanic/thalidomide lesson for the FDA and public health is that rules and guidelines alone are not sufficient to guarantee safety. Continuous vigilance will be required to ensure that all reasonable postmarketing monitoring steps are actually taken to avoid predictable and preventable teratogenic disasters.

On the obligation of physicians to treat AIDS: is there a historical basis?

This study examines the historical bases of what physicians ought to do as well as what they actually have done with regard to the treatment of diseases such as AIDS, which put them at risk for their lives. The earliest explicit statement of what ought to be done goes back only to 1847, when the American Medical Association was founded. However, this statement conflicts with a 75-year-old assertion that physicians have a right to choose whom they will serve. The conflict is compounded by the suspicion that both stated principles were based, at least in part, on socioeconomic considerations rather than moral imperatives. Of what physicians have actually done over the last 2,400 years, little more can definitely be said than that many have not tried to escape mortal risk while others have done so. Thus it is difficult to employ history as a basis for claiming that physicians have an obligation to treat AIDS.

Medicalization and its discontents.

This paper raises the question of the ethically proper balance in health care policy between the medical-clinical-high technology model of health service and the grass-roots, community based or traditional models of care. Paradoxical imbalances between the two approaches are traced to political, economic or prestige factors. Case studies examined include the hospitalization of non-contagious leprosy patients while protecting the anonymity of AIDS-infected prostitutes, medical resistance to the adoption of a clinical role by Community Cancer Centers, and the continued preference in some quarters for elaborate (and often delayed) hospital treatment for such problems as infant diarrhea, despite the availability of much simpler solutions, as in the case of the widely successful oral rehydration therapy. A balanced approach to world health problems, we argue, rests not on inflationary lowering of health care standards to achieve nominal victories, nor on stainless steel high technology panaceas but on mobilizing resources around human needs.

Quarantine and the problem of AIDS.

Through history, quarantine has been a response not only to the mode of disease transmission, but also to popular demands for a boundary between the kind of people so diseased and the respectable people who hope to remain healthy. Efforts to control epidemics--leprosy, cholera, tuberculosis, drug addiction--through quarantine of large numbers of people have never been successful. AIDS patients share characteristics often invoked in defense of quarantine; they do have reason to fear anachronistic and unenlightened outrage.